Arkolith/Insider Trading/AMLX/Form 4

Mazzariello Gina

Chief Legal OfficerAmylyx Pharmaceuticals, Inc. (AMLX) · full profile →Form 4 · filed Apr 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$32K
Net Open-Market Flow
-$32K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2025Sell(S)9K$3.48$32K188K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-049560) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML